Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

Important Notice to Long-Term Shareholders of Erasca, Inc. (NASDAQ: ERAS); Insulet Corporation (NASDAQ: PODD); New Era Energy & Digital, Inc. (NASDAQ: NUAI) (formerly known as New Era Helium (NASDAQ: NEHC)); and Power Solutions International, Inc. (NASDAQ: PSIX): Grabar Law Office is Investigating Claims on Your Behalf

$ERASPress releaseAug 26, 2026, 8:02 AM ETRead the release

Grabar Law Office is investigating Erasca's officers and directors for potential breaches of fiduciary duty related to public disclosures concerning drug candidate ERAS-0015. The investigation centers on allegations that the company made materially misleading statements comparing ERAS-0015 to Revolution Medicines' RMC-6236 and failed to adequately disclose associated intellectual property risks.

AI analysis

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.